Get the Stockscreener App
4.455
2.41%
0.105
Bionexus Gene Lab Corp stock is traded at $4.455, with a volume of 3,264.
It is up +2.41% in the last 24 hours and down -14.33% over the past month.
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
See More
Previous Close:
$4.35
Open:
$4.41
24h Volume:
3,264
Relative Volume:
0.03
Market Cap:
$8.00M
Revenue:
$9.26M
Net Income/Loss:
$-941.60K
P/E Ratio:
-61.88
EPS:
-0.072
Net Cash Flow:
$-2.65M
1W Performance:
-1.66%
1M Performance:
-14.33%
6M Performance:
+49.50%
1Y Performance:
+52.62%
1-Day Range:
$4.41
$4.515
1-Week Range:
$4.35
$4.94
52-Week Range:
$2.0068
$15.60
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
Name
Bionexus Gene Lab Corp
Sector
Industry
Phone
1-307-241-6898
Address
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Compare BGLC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
0.343 | 201.51M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
2.15 | 3.06B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
19.51 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.15 | 166.65M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.22 | 492.74M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
0.72 | 0 | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp Stock (BGLC) Latest News
How interest rate cuts could boost BioNexus Gene Lab Corp. stock2025 Geopolitical Influence & Reliable Volume Spike Alerts - newser.com
Will BioNexus Gene Lab Corp. stock outperform growth indexesDividend Hike & Real-Time Stock Entry Alerts - newser.com
Why BioNexus Gene Lab Corp. stock remains a top recommendation2025 Top Decliners & Proven Capital Preservation Methods - newser.com
Is BioNexus Gene Lab Corp. stock reversal real or fakeDay Trade & Breakout Confirmation Trade Signals - newser.com
Will BioNexus Gene Lab Corp. stock outperform Nasdaq indexQuarterly Portfolio Summary & Weekly Setup with High ROI Potential - newser.com
Is BioNexus Gene Lab Corp. stock bottoming out2025 Price Momentum & Daily Market Momentum Tracking - newser.com
Why BioNexus Gene Lab Corp. stock is in analyst buy zoneEarnings Beat & AI Enhanced Trading Alerts - newser.com
Chart based exit strategy for BioNexus Gene Lab Corp.July 2025 Decliners & Consistent Growth Equity Picks - newser.com
Chart overlay techniques for tracking BioNexus Gene Lab Corp.2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
Pattern recognition hints at BioNexus Gene Lab Corp. upsideTake Profit & Fast Entry High Yield Tips - newser.com
BioNexus Gene Lab Corp. stock chart pattern explained2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
Is BioNexus Gene Lab Corp. stock a buy before product launchesWeekly Risk Summary & Precise Buy Zone Tips - newser.com
Using portfolio simulators with BioNexus Gene Lab Corp. includedEarnings Overview Report & Capital Efficiency Focused Strategies - newser.com
What MACD signals say about BioNexus Gene Lab Corp.Quarterly Profit Summary & High Accuracy Investment Entry Signals - newser.com
BioNexus Gene Lab Corp SEC 10-Q Report - TradingView
What to do if you’re stuck in BioNexus Gene Lab Corp.Weekly Market Outlook & Expert Verified Stock Movement Alerts - newser.com
Is BioNexus Gene Lab Corp. stock a smart buy before Fed meeting2025 EndofYear Setup & Risk Controlled Stock Pick Alerts - Fundação Cultural do Pará
Check Out BioNexus Gene Lab Corp (BGLC)’s Trade Data Rather Than the Analysts’ Views - setenews.com
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization - BioSpace
BioNexus Gene Lab forms partnership to commercialize liquid biopsy platform By Investing.com - Investing.com Nigeria
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic - GlobeNewswire
BioNexus Gene Lab Corp. Announces Strategic Agreements with Fidelion Diagnostics Pte. Ltd. and Tongshu Biotechnology (Hong Kong) Co., Limited for Southeast Asia MRD Commercialization - MarketScreener
BGLC Stock Tumbled Over 13% Today: Why Is VitaGuard Commercialization Agreement Drawing Investor Attention? - Asianet Newsable
BioNexus Gene Lab forms partnership to commercialize liquid biopsy platform - Investing.com India
BioNexus Gene Lab stock soars after strategic MRD testing agreements By Investing.com - Investing.com Philippines
BioNexus Gene Lab stock soars after strategic MRD testing agreements - Investing.com
Bionexus Gene Lab Corp Stock (BGLC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):